# Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia

> **NCT00112203** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 466 (actual)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Itopride

## Key facts

- **NCT ID:** NCT00112203
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2006-07
- **Final completion:** 2006-09
- **Target enrollment:** 466 (ACTUAL)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00112203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00112203, "Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00112203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*